The Effect of Cognitive Behavior Stress Management   Program on the Distress, Coping Skills, and the Social Support of Omani Women with Breast Cancer: A Pilot Study by Shams, Nishat & Al-Azri, Mohammed
  
170 
 
 American Scientific Research Journal for Engineering, Technology,  and Sciences  (ASRJETS) 
ISSN (Print) 2313-4410, ISSN (Online) 2313-4402 
© Global Society of Scientific Research and Researchers  
http://asrjetsjournal.org/  
 
The Effect of Cognitive Behavior Stress Management   
Program on the Distress, Coping Skills, and the Social 
Support of Omani Women with Breast Cancer: A Pilot 
Study 
Nishat Shamsa*, Mohammed Al-Azrib 
aMinistry of Health,P.Box 390,Muscat Shatti Qurum, Oman 
bSultan Qaboos University Hospital, P. Box:3 Muscat -Al Khoudh-Oman 
aEmail: baqra2@yahoo.com, bEmail: mhalazri@gmail.com 
Abstract 
Cognitive behavior stress management (CBSM) is an effective intervention that is suitable for use with women 
who have been diagnosed with breast cancer; however, the effectiveness of CBSM in an applied clinical setting 
has not been examined in an Omani cultural context. Therefore, we examined the effectiveness of an 8-week 
CBSM group program using a sample of 6 Omani women who had been diagnosed with early-stage breast 
cancer. The purpose of this case study was to examine clinically significant changes in distress, social support, 
and the psychological ability to cope with breast cancer from pretest to posttest and follow-up (i.e., 1 month 
later). Overall, the group yielded strong positive effect sizes indicating clinical improvement over time in 
distress symptoms and social support, but strong unfavorable effect sizes in cognitive avoidance. All women 
met the measurement criteria for anxiety and depression at baseline. The 2 participants who had the highest 
levels of baseline distress demonstrated the most pronounced improvements in depression and anxiety at 
posttest; however, their scores had returned to baseline levels at follow-up. On the other hand, the qualitative 
feedback of all 6 women underscored the effectiveness of the program in facilitating cognitive restructuring, 
relaxation, and social support. The present findings offer preliminary support to the effectiveness of CBSM in 
reducing psychological distress, improving coping skills, and fostering social support skills among Omani 
women with breast cancer. However, the program also had a few unfavorable results with regard to one coping 
strategy, namely, cognitive avoidance. Nevertheless, the findings suggest that social support can alleviate 
distress and improve coping skills among Omani women who struggle with breast cancer and its treatment. 
Further, strategies that can address cognitive avoidance and temporally sustain the positive effects of CBSM 
must be examined in future studies.  
----------------------------------------------------------------------- 
* Corresponding author.  
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1. Introduction 
The Sultanate of Oman is a developing Asian country that has an efficient healthcare system, which offers free 
medical services to Omani nationals and non-Omani individuals who work for the government through the 
Ministry of Health [4,6]. Breast cancer is the most common type of cancer among Omani women, compared to 
other countries in the world [7,8,9]. According to the authors in [4], one out of every five Omani women lives 
with breast cancer. This indicates that 15.6 women per 100 000 female inhabitants of Oman are in need of breast 
cancer treatment.  
In Oman, the late stage and early age presentation of breast cancer; however, there has been an improvement in 
the 5-year relapse-free survival (RFS) and 5-year overall survival (OS) of Omani women with breast cancer. 
This improvement in RFS and OS is due to the use of advanced treatment modalities, including updated 
chemotherapy and treatment protocols [4,6]. Despite the high prevalence of advanced breast cancer among 
Omani women, their survival rates have significantly improved. The survival rate of Omani women with breast 
cancer is currently 78 %, and it used to be 64 % between the years of 1996 and 2002 [7]. 
Omani women have significantly high rates of breast cancer incidence and associated mortality. The authors in 
[7] found that Omani women suffered from high levels of anxiety, depression, and a distorted view of the world, 
the future, and the self. Further, feelings of low self-confidence, self-esteem, and self-efficacy were found to be 
directly related to depression and anxiety [7]. The authors in [7] also found that these women experienced the 
fear and depression that were precipitated by complications of cancer, medication side effects, and the fear of 
cancer recurrence on a daily basis. However, they also used several strategies to cope with the disease, including 
wishful thinking, emotional expression, family and social support, yoga exercise, and increased religious 
practice [7]. In studies that have been conducted among breast cancer patients in Saudi Arabia, the participants 
reported that their faith helped them cope with the pain and suffering that they experienced during the entire 
traumatic period of diagnosis and treatment [7]. Their faith in Allah’s (God) power to heal them filled them with 
hope, and they accepted that that their diagnosis of breast cancer was accorded by Allah’s will; this improved 
their ability to cope with their predicament. The role of religion in reducing the distress that the treatment and 
pain of breast cancer entails has been further validated by scholars [4,7,10,15] who have conducted studies 
among Muslim women with breast cancer in Iran, Egypt, and Turkey. 
Denial is one of the coping strategies that Omani women use to adapt to the challenges of a breast cancer 
diagnosis [7,19,20]. Nonetheless, this coping mechanism could delay their initiative to seek early treatment [7]. 
In a study that was conducted among Egyptian Arabic women with breast cancer, the authors in [10] found that 
denial was a coping style that allowed the women to distance themselves from negative thoughts and feelings, 
and foster hope about the treatment outcomes of breast cancer. However, it was also observed that denial 
delayed their initiative to seek medical attention; hence, denial was associated with the metastasis of cancer 
[10].  
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The presentation of advanced cancer ailments is common among cancer patients in developing countries. A lack 
of mass education about breast cancer, cultural barriers, ineffective screening programs, and a poor literacy rate 
are a few of the common factors that are responsible for advanced-stage presentations of cancer. According to 
the World Health Organization [27,28], the number of breast cancer cases is lower in the Middle East than in 
Western countries. However, the mortality rates of women who are diagnosed with breast cancer are much 
higher in Middle Eastern countries than in Western countries [16]. The WHO explained that this might be the 
case because the people who live in Arab nations do not receive regular screening checkups, which will ensure 
the early detection and treatment of cancer. The sociodemographic characteristics that were associated with a 
delay in seeking medical treatment were an older age, a low educational level, and the occupational status of 
being a housewife. In a mixed-methods study, the authors in [17] examined the factors that influenced Omani 
women’s level of breast cancer awareness and early detection practices. A total of 369 women consented to 
participate in their study and completed a questionnaire [17]. Out of the total sample, 68 (19 %) women had 
poor knowledge, 219 (59 %) women had average knowledge, 77 (21 %) women had good knowledge, and five 
(1 %) women had excellent knowledge about breast cancer [17]. These findings showed that there was a lack of 
awareness and knowledge about breast cancer symptoms among Omani women. The researchers also showed 
that general awareness about breast cancer was significantly associated with age, education, income, and 
familiarity with cancer patients, and that early detection of breast cancer was significantly associated with age, 
marital status, and education. A majority of the women (59.5 %) endorsed the belief that an “evil eye” or envy 
from others is a risk factor for breast cancer [17]. The women also articulated the various factors that could 
empower or inhibit their awareness; these included the cultural-religion-fatalistic system, personal-familial-
environmental system, and healthcare-political-social system [17]. The findings of this study were consistent 
with previous findings that Arab women tend to have low levels of knowledge about breast cancer symptoms, 
investigations, and treatment options [18]. 
In comparison to Western countries, a majority of Omani women who are diagnosed with breast cancer face 
advanced cancer ailments (Stage III or IV), and they tend to be a decade younger than their Western 
counterparts [6,7,26]. In addition, it is still common for Omani women to not speak about their condition due to 
the shame and stigma that is attached to breast cancer in Omani society; this may result in a delay in diagnosis 
[1].  
Breast cancer diagnosis remains one of the main causes of distress among female cancer patients in Oman [20]. 
Depression, fear, and stress, which are the most experienced forms of cancer- related psychological disorders, 
have a negative impact on the hypothalamic-pituitary-adrenal (HPA) axis. The persistent stimulation of the HPA 
axis during a chronic stress response and a depressive episode weakens the immune response and contributes to 
the development and progression of some types of cancer. Further, both depression and stress are linked to 
decreased natural killer cell cytotoxicity and the T-cell activities that affect processes such as the immune 
surveillance of tumors [21]. Other relevant biological processes that are affected by stress (i.e., an increase in 
DNA damage, the accumulation of somatic mutations, and alterations in DNA repair) may be involved in the 
onset and outcomes of some types of cancer. Future research in the field of psychoneuroimmunology is needed 
to understand the pathways that are involved in the relationship between stress, the HPA, and the immune 
system, with respect to cancer onset and progression [20,22].  
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Distress is an element of a patient’s clinical presentation [23]. Depression, anxiety, and posttraumatic stress 
disorder (PTSD) symptoms are present in approximately 20 % to 66 % of women during the 12 months that 
follow a breast cancer diagnosis [24]. The symptoms of distress that women with breast cancer experience 
include concerns about the illness and a decline in health, sleep disturbances, poor appetite, anger management 
skills, concentration difficulties, and preoccupation with thoughts about death [National Comprehensive Cancer 
Network Distress Management Panel, 2005]. Anxiety and fear about cancer recurrence are also issues that breast 
cancer patients face [26]. Psychotropic medications like anxiolytics, hypnotics, and antidepressants [25] have 
been used to alleviate the distress and pain that breast cancer patients experience; however, pharmacological 
interventions have not been successful in alleviating pain and distress [26]. Thus, it is crucial to examine non-
pharmacological approaches that can alleviate the depression, pain, and anxiety that are associated with breast 
cancer.  
The latest psychological interventions like psycho-educational programs, mindfulness-based therapies, and 
support groups effectively facilitate adjustment to a cancer diagnosis [27,28]. In studies on cognitive behavior 
therapy (CBT), the authors [29] demonstrated its beneficial outcomes for disease-related symptoms, emotional 
distress, and functional adjustment. The most effective CBT program that has been designed for breast cancer 
patients is the Cognitive Behavior Stress Management (CBSM) [30] Program, which addresses five core areas: 
improving coping skills and emotional expression, increasing awareness to one’s stress response, and teaching 
anxiety-reduction and cognitive restructuring skills. CBSM enhances benefit-finding [30,31], alleviates 
depression, anxiety, and intrusive thoughts  [33,34,37], and improves immune function and the quality of one’s 
life [33]. A recent study [31] showed that out of 15 studies on psychological intervention, CBT was more 
effective in improving depression, fatigue, and physical functioning when compared to standard care. Cognitive 
Behavioral Stress Management (CBSM), has validated efficacy in several chronic illnesses [28]. In another 
study [25] CBSM interventions reduce distress by utilizing relaxation skills, coping methods, cognitive appraisal 
and modifying patients' outlook. CBSM applied in a group format with cancer patients also improve the 
perceptions of social support [33]. Group-based CBSM decreases overall stress level and improves quality of 
life and anxiety by modulating cortisol output, and recovers cellular immune functioning among patients 
tackling with immunomodulating diseases or treatments [23, 24]. 
Although the empirical basis for CBSM is strong, there were no previous studies conducted in Oman to examine 
the program’s efficacy in the applied clinical setting for breast cancer management strategy. CBSM has been 
implemented only during the time of diagnosis. This is an appropriate target for empirical studies because the 
distress levels of cancer patients are usually elevated at the time of diagnosis. However, in applied clinical 
settings, patients may be referred for CBSM at any stage of their treatment plan. Thus, group programs have a 
mixed composition of current patients, recent completers, and long-term survivors. The feasibility of CBSM in a 
mixed group has not been examined. In addition, there are no published CBSM studies found in populations 
outside of the Western world.  
In this case study, we evaluated the effectiveness of a CBSM group program that was offered by a psychologist 
within the oncology department of Sultan Qaboos University Hospital. In this project, we aimed to examine 
whether CBSM is effective in alleviating distress, enhancing social support, and promoting adaptive coping 
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strategies among Omani breast cancer patients and survivors.  
2. Method 
Omani culture is different from Western traditions. Therefore, some aspects of the therapeutic design of the 
CBSM program were customized to suit the Arab culture. There are several significant cognitions from the 
Islamic faith that can be assimilated into the counseling process with Muslim clients to ensure that the cognitive 
restructuring model, core beliefs, and the client’s dysfunctional automatic thoughts are identified. This process 
involves an evaluation and alteration of automatic thoughts, and subsequently, the restructuring of core beliefs 
and assumptions. Modification occurs primarily through an examination of the evidence and the search for 
alternative explanations; other methods may also be used. The client is encouraged to question, evaluate, and 
restructure their dysfunctional thoughts and beliefs. Islamic beliefs can be offered as alternatives to the 
dysfunctional thoughts that are associated with distress. The principles of this method are based on the 
cognitive-behavioral model of the author in [34], and it has been adapted to suit the religious principles and 
sociocultural context of Oman. The sample size was determined based on pragmatic considerations; indeed, case 
studies are one of most effective means to stimulate new research. If the findings of the present study are 
deemed valuable, they can lead to new and progressive research in this field. The wide range of studies that have 
already been conducted would not have been possible without the case study methodology [24]. Since this study 
was the first of its kind to be conducted in Oman, we decided to use the case study method and a sample of six 
Omani women with early breast cancer. 
2.1. Measurement/procedure 
2.1.1. Measures 
2.1.1.1. Distress 
Anxiety and depression were measured using the short version of the Depression Anxiety Stress Scales (DASS-
21; Lovebird, 1995). It is a 21-item self-report measure that has adequate psychometric validity and reliability 
for both community and clinical populations (Antony and his colleagues 2006). The depression subscale 
measures dysphoria, self-deprecation, lack of interest, anhedonia, and hopelessness. The anxiety subscale 
measures autonomic arousal, situational anxiety, subjective experience of anxiety affect, and skeletal 
musculature effects. The participants indicated the frequency with which they had experienced each item during 
the past week on a 4-point scale that ranged from 0 (did not apply to me at all) to 3 (applied to me very much or 
most of the time). A composite score was computed by summing the individual item scores for each 7-item 
subscale. The resultant scores were doubled so that the ranges were identical to the original 42-item 
assessments. Thus, scores could range from 0–42, and higher scores were indicative of a greater severity of the 
respective symptoms [36]. The subscale scores can be further categorized as normal, mild, moderate, severe, 
and extremely severe based on conventional cutoff scores. In the present study, these cutoff scores were used as 
a measure of clinically significant change.  
2.1.1.2. Coping 
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The short form of the Mental Adjustment to Cancer scale (Mini-MAC) [37] consists of 29 items that assess five 
factors: fighting spirit (four items), fatalism (five items), anxious preoccupation (eight items), 
helplessness/hopelessness (eight items), and cognitive avoidance (four items). The participants indicated the 
extent to which each statement currently applied to them on a 4-point scale; a composite score was calculated by 
summing the items for each corresponding domain. The possible range of scores was 4–16 for cognitive 
avoidance and fighting spirit, 5–20 for fatalism, and 8–32 for anxious preoccupation and 
helplessness/hopelessness; higher scores were indicative of a greater use of the respective coping style. The 
psychometric properties and factor structure of the mini-MAC have been well-established [37].  
2.1.1.3. Social support 
The 19-item Medical Outcomes Study Social Support Survey [38] was developed using a sample of 
approximately 4000 patients who had chronic health conditions. Participants were required to indicate the 
frequency with which each type of social support was available to them at times when they required it on a 5-
point rating scale (1 = none of the time, 2 = a little of the time, 3 = some of the time, 4 = most of the time, 5 = all 
of the time). The total scale score was used in the present study. It can be computed by averaging the individual 
item scores and transforming the resultant values based on a 0–100 scale; higher scores are indicative of higher 
levels of perceived social support accessibility. The psychometric properties of this scale have been well-
established [38].  
2.1.1.4. Qualitative post-treatment feedback  
Participants were required to complete a short feedback form, in addition to the measures that have been 
previously presented. This form contained items that assessed the extent to which participants were satisfied 
with (a) the content of the program, (b) the pace of the program, (c) its efficiency in addressing their presenting 
problems, and (d) the recommended changes. Participants were required to respond to each of these items on a 
5-point rating scale that ranged from 1 (unsatisfactory) to 5 (very satisfactory). The form also contained a blank 
space that participants could use to provide qualitative feedback about the program content. 
2.2. Setting 
The population that was of interest to the present study was women who were diagnosed with breast cancer in 
Oman. The Participants were recruited from the Sultan Qaboos University Hospital (SQUH).  This hospital was 
chosen because it is one of the primary hospitals in the country that provides complete cancer treatment. Patients 
who attended the inpatient and outpatient oncology clinics in SQUH were approached; patients who were 
receiving chemotherapy in the daycare room in SQUH were also requested to participate in the study. 
2.3. Participants 
The participants were selected from the inpatient and outpatient oncology units of SQUH, Muscat. The sample 
inclusion criteria were as follows: aged 18 years or older, Omani by birth, cognitively intelligent (i.e., able to 
understand the content of the program and provide informed consent), possession of basic Arabic writing skills, 
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and a diagnosis of Stage I breast cancer. The participants were not required to meet the DSM-V diagnostic 
criteria, as the program was advertised as one that would merely offer therapeutic and general support. Ethical 
approval for the present study was obtained from the Local Ethics Committee of the Sultan Qaboos University. 
We conducted the program in accordance with Oman’s medical rules and regulations that are prescribed by the 
national statutes, and the participating institution’s in-house policies.  
2.3.1. Participant A 
Participant A was a 47-year-old woman who had received her diagnosis 2 months prior to the baseline 
psychological assessment. Her medical treatment plan consisted of a unilateral mastectomy and adjuvant 
chemotherapy during the entire course of the group program. Her presenting problems pertained to coping with 
cancer (e.g., anger and depression related to her diagnosis) and the associated feelings of grief and loss. Patient 
A exhibited anger and blamed the local healthcare centers of the country for her late diagnosis. According to 
her, the healthcare clinicians had failed to notice the signs of breast cancer at an early stage, thereby delaying 
her referral to primary tertiary treatment facility. She was not under the influence of any mood medication at the 
time of the assessment. 
2.3.2. Participant B 
Participant B was a 51-year-old woman who had been diagnosed with invasive breast cancer 2 months prior to 
the assessment. Her medical history showed that she had also suffered a previous ductal carcinoma in situ. She 
required only a mastectomy, and she had completed her treatment before the commencement of the group 
program. She presented with anxiety about cancer recurrence, stress management, feelings of emotional 
vulnerability, and difficulties with assertiveness. Participant B was not under the influence of any mood 
medication at the time of the assessment. 
2.3.3. Participant C 
Participant C was a 46-year-old female who had received her diagnosis 5 months prior to the assessment. Her 
treatment regimen consisted of a partial mastectomy and chemotherapy. The radiotherapy treatment was 
initiated during the course of the group program. Her presenting problems included feelings of 
helplessness/hopelessness, depression, and interpersonal/relationship difficulties. She reported feeling anxious 
about the treatment procedures in SQUH because she had initially been treated outside Oman and was satisfied 
with the level of care that she had received. Participant C was not under the influence of any mood medication at 
the time of the assessment.  
2.3.4. Participant D  
Participant D was a 42-year-old woman who had received her diagnosis 16 months prior to the assessment. Her 
medical treatment, which had been completed at the time of assessment, had consisted of bilateral mastectomies, 
chemotherapy, radiotherapy, and a prophylactic hysterectomy because she had tested positive for the BRCA-II 
gene. Her presenting problems included anxiety, depression, anger, and a loss of self-confidence. She was not 
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under the influence of any mood medication at the time of the assessment. 
2.3.5. Participant E  
Participant E was a 45-year-old woman who had received her diagnosis 9 months prior to the assessment. Her 
medical treatment consisted of a mastectomy and chemotherapy. She was receiving adjuvant Herceptin 
treatment (a targeted gene therapy medication) during the course of the group program. Her presenting problems 
included feelings of emotional vulnerability, anxiety about her family’s well-being, and feelings of isolation. 
This participant also expressed concerns about her poor knowledge about breast cancer and its treatment. She 
was not under the influence of any mood medication at the time of assessment. 
2.3.6. Participant F 
Participant F was a 46-year-old woman who had received her diagnosis 2 months prior to the assessment. Her 
medical treatment included chemotherapy. She was receiving adjuvant therapy during the course of the group 
program. Her presenting symptoms included feelings of sadness and anxiety that were primarily due to the side 
effects of chemotherapy. She also reported anxiety about cancer recurrence, general life-related worries, and 
concerns about grief and loss.     
2.4. Procedure 
The participants individually completed a semi-structured (pre-intervention) assessment. This was used to 
establish the eligibility, presenting problems, and treatment goals of the participants. A number of self-report 
measures were administered as a part of the assessment. Subsequently, the intervention was conducted, and the 
self-report assessment was re-administered at the end of the final group session (post-intervention). 
Additionally, the assessment questionnaire (follow-up) was mailed to the participants 1 month after the 
completion of the group program. The participants gathered in a room that was equipped with chairs that could 
be used for relaxation exercises, group discussion, and psycho-educational components. The group leader   was 
a psychologist who had received doctoral-level training in CBT and relaxation therapy techniques. 
2.5. The intervention 
The CBSM intervention was delivered using a structured closed group format. Each of the 8 weekly sessions 
lasted for 2 hours [30]. Each session comprised two major components: relaxation and cognitive therapy. 
Weekly homework assignments, such as writing down one’s negative thoughts (Arabic/English) about breast 
cancer, were provided to the participants (blank notebooks were provided to patients). The topic of each session 
was founded on the concepts that had been introduced in the previous session. The topics that were addressed 
included the following: (a) an introduction to the stress response, (b) the cognitive model, (c) automatic thoughts 
and common unhelpful thought patterns, (d) cognitive restructuring, (e) an introduction to these authors’ [39] 
coping model, (e) coping and acceptance, (f) social support, (g) anger management, (h) assertive 
communication, and (i) relapse prevention/treatment summary. The women were taught breathing exercises 
during the third session. The patients were encouraged to practice relaxation exercises with the assistance of the 
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psychologist during the session and to continue to independently practice them once a week. Arabic and English 
instructional handouts on relaxation exercises were provided to the participants. We ensured that the instructions 
were in a simple language with respect to Arab culture.  
2.6. Analysis 
Two indicators of clinically significant changes were used. First, within-subjects effect sizes (Cohen’s d) were 
calculated using the following formula to determine whether the intervention had led to any temporal 
improvements in the group:  
d = MT1-MT2/SDpooled                        (1) 
In this equation, MT1 refers to the raw mean score at baseline, MT2 refers to the raw mean score at the end of 
the intervention or at follow-up, and SDpooled refers to the average standard deviation of the sample. Therefore, 
a positive effect size indicates that the score had reduced over time, and a negative effect size indicates that the 
scores had improved over time. Values of 0.2, 0.5, and 0.8 are indicative of a small, moderate, and large effect 
size, respectively [40]. Clinically significant individual changes in distress was examined using the established 
clinical cutoffs for the DASS, and the qualitative feedback was analyzed thematically.  
3. Results 
The participants of this study attended an average of 8.8 sessions (SD = 0.84, Range = 8–10). The within-group 
effect sizes for all the study variables are presented in Table 1. Table 2 shows individual changes in depression 
and anxiety based on the respective clinical cutoffs. Individual temporal changes were examined for outcomes 
that evidenced large effect sizes at the group level.  
Table 1: Clinical significance from prepost and pre-follow-up of the Group: Effect sizes for social support, 
distress, and coping  
Variable d: Pretest versus posttest d: Pretest versus follow-up  
Distress   
Anxiety 0.29 0.24 
Depression 0.54 0.13 
Coping   
Fighting spirit -0.04 0 
Anxious preoccupation 0.41 0.52 
Cognitive avoidance -0.18 -2.18  
Helpless/hopeless -0.04 0.39 
Fatalism 0 0.14 
Social support 0.92 -0.74 
Note. Interpretation of effect sizes: d = 0.2 (small effect size), d = 0.5 (moderate effect size), and d = 0.8 (large 
effect size). 
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Table 2: Individual clinical outcomes for distress 
Participant     Time Participant 
A 
Participant 
B 
Participant C Participant D Participant 
E 
Participant 
F 
 Time Participant 
A 
Participant 
B 
Participant C Participant D Participant 
E 
Participant 
F 
Depression Pretest 6 (Normal) 20 
(Moderate) 
32 (extremely 
severe)  
22 (severe) 0 (normal) 18 
(Moderate) 
 Posttest 6 (Normal) 18 
(Moderate) 
8 (normal) 10 (mild) 4 (normal) 6 (normal) 
 Outcome Unchanged Unchanged Recovered Improved Unchanged Unchanged 
 Follow-
up 
8 (Normal) 10 (Mild) 42 (ext. 
severe 
16 (Moderate) 0 (normal) 10 (Mild) 
 Outcome Unchanged Improved Deteriorated Deteriorated 
(overall 
improved) 
Unchanged  Improved 
Anxiety Pretest 8 (Mild) 4 (Normal) 18 (severe) 20 (extremely 
severe) 
2 (normal) 18 (Mild) 
 Posttest 8 (Mild) 6 (Normal) 12 (moderate) 6 (normal) 8 (mild) 6 (Mild) 
 Outcome Unchanged Unchanged Improved Recovered Deteriorated  Improved 
 Follow-
up 
2 (Normal) 2 (Normal) 22 (extremely 
severe) 
16 (severe) 0 (Normal) 2 (Normal) 
 Outcome Improved Unchanged Deteriorated Deteriorated Improved Improved 
 
3.1. Distress 
Table 1 shows that the CBSM program resulted in a reasonable decline in depression from pretest to posttest (d 
= 0.54); however, this trend was not sustained at follow-up.  
Table 2 shows that there was a significant and substantial temporal decline in depression between pretest and 
posttest for Participants C (current patient) and D (survivor). However, these improvements were not sustained 
at follow-up, and their scores had lowered to the baseline levels. Participants B and F demonstrated a clinically 
significant improvement between pretest and posttest (moderate), and follow-up (mild). Participants A and E’s 
depression scores were in the normal range at all time points.  
For anxiety, the intervention had a slight effect size. Specifically, although Participants C and D demonstrated 
clinically significant diminutions at posttest, they had rebounded at follow-up (Table 2). Two participants (A 
and F) demonstrated a clinically significant improvement between pretest and posttest (mild), and follow-up 
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(normal). Two participants’ (B and E) scores were normal at baseline, and they remained unchanged across 
time.  
3.2. Coping and social support 
As shown in Table 1, there was a large clinically significant escalation in cognitive avoidance from pretest to 
follow-up (d = 2.18). Figure 2 shows that from pre- to post-treatment, four participants (B, D, E, and F) 
expressed reductions, and Participants A and C experienced a rise in avoidance, while all participants increased 
in avoidance from posttest to follow-up. There was no other clinically significant group change in any other 
coping strategy. Cognitive avoidance is an unhealthy coping mechanism that can alleviate the emotional pain 
that is associated with anxiety and depression. For example, generalized anxiety disorder (GAD) is 
characterized by persistent and uncontrollable worry. According to the cognitive avoidance theory of GAD, 
worry may function as an affective damping strategy that is motivated by an intolerance for negative emotional 
states. By enabling the avoidance of distressing cognitions and the associated affect, worry impedes the 
modification of the representation of fear memory, and consequently maintains threats that could perpetuate 
further anxiety and worry.     
As far as social support is concerned, the intervention had a clinically significant effect at posttest, d = 7.92 
(large effect size), and at follow-up, d = 7.74 (moderate/large effect size). Figure 3 shows that there was an 
increase in social support from pretest to posttest for all the participants stated. At follow-up, Participants C, E, 
and F demonstrated further increase in social support, while the remaining participants decreased. 
3.3. Qualitative feedback  
The qualitative feedback that was obtained pertained to three discrete topics: the level of satisfaction with the 
group program, the personal benefits of attending the group program, and how the group helped them in other 
areas of their lives (i.e., generalized benefits).  
3.3.1. Satisfaction with therapy  
All participants rated the therapy length, quality, content, and facilitator as helpful. Further, all six women 
reported that they would like to participate in similar programs that should be more often conducted in the 
oncology unit. All participants also reported that the severity of their presenting problems had declined over the 
course of the program. 
3.3.2. Personal benefits  
The results of the thematic analysis suggest that the intervention had yielded beneficial outcomes in three major 
areas: (a) the opportunity to engage in relaxation exercises, (b) open communication and discussion with other 
women with breast cancer, and (c) learning and practicing cognitive restructuring techniques.  
3.3.3. Generalized benefits 
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Participants were encouraged to report whether the program had any impact on other areas of their lives. All six 
women individually reported that the program had enabled them to talk about their illness with their family 
members. They also reported that they were able to enhance their quality of life by thinking positively and 
engaging in healthier interactions with their family members. 
None of the participants of the program suggested any changes. Instead, all six women stated that they “wished 
the program would be longer and look forward to see these kinds of programs happening more frequent in 
hospital.” 
4. Discussion 
In this pilot study, we sought to evaluate the effectiveness of an existing CBT program, with confirmed, 
validated, empirical efficacy in improving adjustment for six Omani women with breast cancer in an applied 
clinical setting of SQUH. The CBSM program was designed to enhance the general wellbeing of women with 
early-stage breast cancer [30]. To our knowledge, this is the first paper to report the implementation of the 
CBSM program in an applied population outside of the United States with participants at varying points in the 
cancer treatment trajectory. Further, this is the first evidenced-based psychological intervention program that has 
been conducted among Omani women who have been diagnosed with breast cancer. The present findings offer 
partial support for the efficacy of this program. Specifically, the CBSM intervention alleviated depressive 
symptoms, and the corresponding effect sizes were moderate in magnitude and positive in direction at posttest 
and follow-up. Further, CBSM enhanced social support, and the corresponding effect sizes were large in 
magnitude and negative in direction at both posttest and follow-up. However, the benefits must be balanced 
against the negative effects size that was pointed out in cognitive avoidance at the follow-up stage and the lack 
of clinically sustained improvements on coping measures and distress for the two participants (C and D) with 
the highest levels of baseline distress.  
Previous studies that have examined how Arab patients cope with breast cancer have found that their primary 
coping skills include faith, spirituality, and religious beliefs that were endorsed by the family [7]. Given the 
religious support that Omani women receive, the standard CBSM program was tailored in accordance with the 
religious and cultural values of Arab patients. In order to include religious components in the CBSM program, 
the patients were taught to learn to recognize uncomfortable emotions, activating events, negative automatic 
thoughts, talk about their faith in Allah and its desirable effects on automatic negative thoughts, practice 
relaxation (i.e., breathing) exercises, and complete home assignments. Patients were also encouraged to talk 
about their religious notions of good and evil and their reliance on Allah’s power and patience. 
With respect to distress, four participants reported moderate to severe depression at baseline, and three 
participants demonstrated a clinically significant improvement at posttest (Participants C, D, and F). Although 
Participant B did not demonstrate a clinically significant improvement at posttest or at follow-up, her scores had 
changed from being indicative of moderate depression to mild depression at follow-up. On the other hand, 
Participant F demonstrated a consistent reduction in distress from posttest to follow-up. The moderate effect size 
that emerged for the group was not sustained at follow-up; nevertheless, two out of the three depressed 
American Scientific Research Journal for Engineering, Technology, and Sciences (ASRJETS) (2019) Volume 55, No  1, pp 170-187 
182 
 
participants demonstrated a delayed albeit sustained improvement. These results are collectively distinct from 
these authors’ [41] findings that the prevalence of moderate depression had decreased by 20–30 % at posttest, 
and that this effect was sustained at follow-up (i.e., 8 months after the completion of the group program). CBT 
frequently leads to long-lasting gains that sustain even after the treatment ends; this is because participants learn 
to implement and reinforce the skills that they have recently acquired. Although this appears to be applicable to 
Participants B and F, Participants C and D may have failed to use the concepts that were taught to them, thereby 
leading to a rebound effect. 
The CBSM program did not produce consistent changes in anxiety for the four participants who had reported 
anxiety symptoms at baseline. Although Participants C, D, and F demonstrated improvement at posttest, 
Participant E’s symptoms deteriorated from normal to mild, and Participant A’s mild symptoms remained 
unchanged. Thus, the program was effective only for the women who had severe levels of baseline anxiety. At 
follow-up, the scores of Participants C and D were similar to what was observed at baseline; on the other hand, 
those who had reported mild anxiety demonstrated an improvement (Participants A and E). Participant F who 
had high levels of anxiety at baseline had mild levels of anxiety at follow-up. These findings can be summarized 
as follows: (a) mild anxiety might not consistently respond to group CBT and may resolve outside the 
therapeutic setting and (b) severe anxiety can be adequately addressed by group therapy; consequently, 
additional booster sessions are required to augment the CBT skills that participants acquire during the program. 
This overall lack of sustained effect that was found in the present study is similar to these authors’ [41] finding 
that the program did not influence general mood disturbances. However, it contradicts these authors’ [33] 
finding that the levels of distress and anxiety of highly distressed participants who had undergone a CBSM 
program had reduced, and that this effect was sustained across a 12- month period.  
The high levels of cognitive avoidance rose for all six women even after the group concluded. This implies that 
the group was effective at alleviating avoidance while women were actively engaged in skill gaining, and it is an 
area meriting further attention [33]. The primary contribution of the present study is toward the facilitation of 
social support, which has not been explored as an outcome of the CBSM program. Social support is a worthy 
intervention outcome because one of the CBSM modules is dedicated to this topic. One of the primary reasons 
for running the group program using the selected format is to build a reliable social support framework for 
women suffering with the same type of illness to share their experiences with each other in a group program. 
Therefore, the clinically significant improvement in social support that was observed from pretest to follow-up 
implies that the design of the CBSM program (i.e., in a group setting) achieved its dual purpose. Such a 
contention was also supported by the qualitative feedback, whereby all women reported that the support that 
they received from each other was one of the beneficial outcomes of the program. With regard to the individual 
trajectories, all six participants demonstrated an improvement in social support across the 8-week program. 
However, only three participants (C, E, and F) continued to report further minor improvements between posttest 
and follow-up. Of the two participants whose distress scores returned to baseline levels, the total social support 
score was higher for Participant C and lower for Participant D at follow-up. 
Regardless of the time of diagnosis, all six women achieved clinically significant improvements on two 
measures of distress at either posttest or follow-up. The findings of this study can be applied across the spectrum 
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during the breast cancer treatment and posttreatment phase. This contention is further supported by the 
qualitative feedback: all six participants considered the program content and group facilitator to be helpful and 
satisfactory. Although demand-effects were likely to have influenced this finding, other metrics also suggested 
that the program was well received. Indeed, the retention rate of the present study was 100 % (the minimum 
number of sessions that was attended by each participant was eight). 
The findings of the present study offer preliminary support to the contention that the CBSM group is an 
effective intervention that can be used in applied clinical settings to alleviate the traumatic stress that Omani 
women with breast cancer experience. The intervention was well- received, and it was relevant to women who 
differed in their temporal positions within the treatment trajectory. Unfortunately, however, the program did not 
lead to enduring improvements. The CBSM module that was used in this study can be implemented in health 
institutions in Oman. However, it requires continuous modifications to ensure the maintenance of the resultant 
improvements in symptoms and coping skills. Further, there is a need to educate Omani women about breast 
cancer by means of routine booster sessions. It is also important to respect the religious and cultural beliefs of 
Arab women by redesigning the CBT program in such a manner that it includes components that are grounded 
in the Islamic faith. 
5. Limitation 
The conclusions that have been drawn about the beneficial outcomes of this CBT program only provide 
preliminary evidence about its applicability in an applied clinical setting. Given that the present study used a 
case study methodology, small sample size and dependency on self-report measures, the findings have limited 
generalizability. Therefore, a replication study that employs a larger sample size is required in future. Given that 
our sample was predominantly Omani women with a  low  education, generalizability of results is also  
questionable. 
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Figure 1: temporal changes in cognitive avoidance 
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Figure 2: temporal changes in social support  
6. Conclusion 
The present findings are consistent with those of previous studies. Similar to women around the globe, Omani 
women also experience significant distress when they receive a breast cancer diagnosis and undergo the 
corresponding treatment. If these conditions are left untreated, they can lead to serious medical and health 
consequences, and adversely impact the quality of life and healthcare expenditure of patients. Therefore, the 
incorporation of psychological services into the medical treatment package may alleviate depression and 
anxiety, and consequently improve the quality of life of Omani women with breast cancer. In addition, the 
results of this pilot study indicate the potential benefits and probability of a stress management-based group 
CBSM intervention program for breast cancer patients in Oman. Future work should focus on enlisting a larger 
sample, and comparing the effects of CBSM with those of well-established CBT-based interventions with equal 
contact time to ensure which CBT programs are most appropriate with cancer survivors patients of Oman.  
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